| Code | Display | Comments |
|---|
 93028-9 | Have you spent more than 2 nights in a row in a jail, prison, detention center, or juvenile correctional facility in past 1 year [PRAPARE] | | |
| 93025-5 | Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] | | |
| 69861-3 | Because of a physical, mental, or emotional condition, do you have difficulty doing errands alone such as visiting a physician's office or shopping | | |
| 93027-1 | Are you a refugee | | |
| 81375-8 | Self assessment of health status [Reported] | | |
| 93034-7 | Discharged from the U.S. Armed Forces | | |
| 68516-4 | On those days that you engage in moderate to strenuous exercise, how many minutes, on average, do you exercise | | |
| 96782-8 | Wants help with school or training | | |
| 93029-7 | How often do you see or talk to people that you care about and feel close to [PRAPARE] | | |
| 68517-2 | How many times in the past year have you have X or more drinks in a day | | |
| 96842-0 | How often have you used any tobacco product in past 12 months | | |
| 88123-5 | Within the past 12 months the food we bought just didn't last and we didn't have money to get more [U.S. FSS] | | |
| 76501-6 | Within the last year, have you been afraid of your partner or ex-partner | | |
| 95618-5 | Physically hurt you [HITS] | | |
| 93038-8 | Stress level | | |
| 69858-9 | Because of a physical, mental, or emotional condition, do you have serious difficulty concentrating, remembering, or making decisions | | |
| 93159-2 | How often do you feel lonely or isolated from those around you [CMS Assessment] | | |
| 96780-2 | Wants help finding or keeping work or a job | | |
| 44250-9 | Little interest or pleasure in doing things in last 2 weeks | | |
| 68524-8 | How many times in the past year have you used an illegal drug or used a prescription medication for non-medical reasons | | |
| 88121-9 | Hunger Vital Sign [HVS] | | |
| 93026-3 | Do you feel physically and emotionally safe where you currently live [PRAPARE] | | |
| 82589-3 | Highest level of education | | |
| 89555-7 | How many days per week did you engage in moderate to strenuous physical activity in the last 30 days | | |
| 96781-0 | Able to get help with daily activities when needed | | |
| 95530-2 | Prescription drug use for non-medical reasons in the past year | | |
| 56799-0 | Address | | |
| 63586-2 | What was your best estimate of the total income of all family members from all sources, before taxes, in last year [PhenX] | | |
| 96779-4 | Has the electric, gas, oil, or water company threatened to shut off services in your home in past 12 months | | |
| 93677-3 | Do you need help with legal issues [WellRx] | | |
| 63512-8 | How many people are living or staying at this address [#] | | |
| 76437-3 | Primary insurance | | |
| 88124-3 | Food insecurity risk [HVS] | | |
| 32624-9 | Race | | |
| 97023-6 | Accountable health communities (AHC) health-related social needs (HRSN) supplemental questions | | |
| 93035-4 | Has season or migrant farm work been your or your family's main source of income at any point in past 2 years [PRAPARE] | | |
| 54899-0 | Preferred language | | |
| 93033-9 | Are you worried about losing your housing [PRAPARE] | | |
| 93031-3 | Have you or any family members you live with been unable to get any of the following when it was really needed in past 1 year [PRAPARE] | | |
| 56051-6 | Hispanic or Latino | | |
| 88122-7 | Within the past 12 months we worried whether our food would run out before we got money to buy more [U.S. FSS] | | |
| 93030-5 | Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living | | |
| 97027-7 | Speaks a language other than English at home | | |
| 71802-3 | Housing status | | |
| 44255-8 | Feeling down, depressed, or hopeless in last 2 weeks | | |
| 67875-5 | Employment status - current | | |
| 76513-1 | How hard is it for you to pay for the very basics like food, housing, medical care, and heating | | |
| 1-8 | | Acyclovir [Susceptibility] | |
| 10-9 | | Amdinocillin [Susceptibility] by Serum bactericidal titer | |
| 100-8 | | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 1000-9 | | DBG Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10000-8 | | R wave duration in lead AVR | |
| 100002-5 | | Specimen care is maintained | |
| 100003-3 | | Team communication is maintained throughout care | |
| 100004-1 | | Demonstrates knowledge of the expected psychosocial responses to the procedure | |
| 100005-8 | | Demonstrates knowledge of nutritional management related to the procedure | |
| 100006-6 | | Demonstrates knowledge of medication management | |
| 100007-4 | | Demonstrates knowledge of pain management | |
| 100008-2 | | Demonstrates knowledge of wound management | |
| 100009-0 | | Demonstrates knowledge of the procedure and expected results | |
| 10001-6 | | R wave duration in lead I | |
| 100010-8 | | No injury related to procedure equipment, medical supplies, or instrumentation | |
| 100011-6 | | No injury related to an electrical source | |
| 100012-4 | | Participates in decisions affecting the patient's plan of care | |
| 100013-2 | | Participates in the discharge process | |
| 100014-0 | | Psychosocial health is maintained at or improved from baseline | |
| 100015-7 | | No injury related to positioning due to care or procedure | |
| 100016-5 | | No injury related to a laser source | |
| 100017-3 | | Perioperative nursing data set outcomes panel [PNDS] | |
| 100018-1 | | Hospice care Note | |
| 100019-9 | | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 10002-4 | | R wave duration in lead II | |
| 100020-7 | | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100021-5 | | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100022-3 | | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100023-1 | | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100024-9 | | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100025-6 | | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100026-4 | | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100027-2 | | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100028-0 | | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100029-8 | | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | |
| 10003-2 | | R wave duration in lead III | |
| 100030-6 | | Axis I: Temporal aspects score [Mainz Pain Staging System] | |
| 100031-4 | | Axis II: Spatial aspects score [Mainz Pain Staging System] | |
| 100032-2 | | Axis III: Drug taking behavior score [Mainz Pain Staging System] | |
| 100033-0 | | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | |
| 100034-8 | | Provider of automated external defibrillator use | |
| 100035-5 | | Exam finding location of Chest | |
| 100036-3 | | Exam finding location of Lung | |
| 100037-1 | | Patient contact disposition EMS unit | |
| 100038-9 | | Patient evaluation disposition EMS unit | |
| 100039-7 | | Crew disposition for patient care EMS unit | |
| 10004-0 | | R wave duration in lead V1 | |
| 100040-5 | | Patient transport disposition EMS unit | |
| 100041-3 | | Aminoglycoside [Susceptibility] | |
| 100042-1 | | Atovaquone [Susceptibility] | |
| 100043-9 | | Azithromycin+Ethambutol [Susceptibility] | |
| 100044-7 | | Cefcapene [Susceptibility] | |
| 100045-4 | | Cefozopran [Susceptibility] | |
| 100046-2 | | Cefquinome [Susceptibility] | |
| 100047-0 | | Cefteram [Susceptibility] | |
| 100048-8 | | Clarithromycin+Ethambutol [Susceptibility] | |
| 100049-6 | | Eravacycline [Susceptibility] | |
| 10005-7 | | R wave duration in lead V2 | |
| 100050-4 | | Erythromycin+Ethambutol [Susceptibility] | |
| 100051-2 | | Ethambutol+rifAMPin [Susceptibility] | |
| 100052-0 | | Flomoxef [Susceptibility] | |
| 100053-8 | | Fluoroquinolone [Susceptibility] | |
| 100054-6 | | Gamithromycin [Susceptibility] | |
| 100055-3 | | Optochin [Susceptibility] | |
| 100056-1 | | Panipenem [Susceptibility] | |
| 100057-9 | | Prothionamide [Susceptibility] | |
| 100058-7 | | Prulifloxacin [Susceptibility] | |
| 100059-5 | | Rifapentine [Susceptibility] | |
| 10006-5 | | R wave duration in lead V3 | |
| 100060-3 | | Tildipirosin [Susceptibility] | |
| 100061-1 | | Tosufloxacin [Susceptibility] | |
| 100062-9 | | Standard Dermatology Outcome Measures panel | |
| 100063-7 | | Primary skin concern | |
| 100064-5 | | Itch severity Reporting Period - Reported | |
| 100065-2 | | Satisfied with treatment | |
| 100066-0 | | Specular microscopy panel | |
| 100067-8 | | Eye Image magnification | |
| 100068-6 | | Right eye Fixation point [Angle] | |
| 100069-4 | | Left eye Fixation point [Angle] | |
| 10007-3 | | R wave duration in lead V4 | |
| 100070-2 | | Right cornea Cell density | |
| 100071-0 | | Left cornea Cell density | |
| 100072-8 | | Right cornea Coefficient of variation | |
| 100073-6 | | Left cornea Coefficient of variation | |
| 100074-4 | | Right cornea Hexagonality | |
| 100075-1 | | Left cornea Hexagonality | |
| 100076-9 | | Right cornea Endothelial cells counted | |
| 100077-7 | | Left cornea Endothelial cells counted | |
| 100078-5 | | Right cornea Endothelial cell area.min | |
| 100079-3 | | Left cornea Endothelial cell area.min | |
| 10008-1 | | R wave duration in lead V5 | |
| 100080-1 | | Right cornea Endothelial cell area.max | |
| 100081-9 | | Left cornea Endothelial cell area.max | |
| 100082-7 | | Right cornea Endothelial cell area.mean | |
| 100083-5 | | Left cornea Endothelial cell area.mean | |
| 100084-3 | | Right cornea Cell area.standard deviation | |
| 100085-0 | | Left cornea Cell area.standard deviation | |
| 100086-8 | | Right cornea Type of Analysis method by Specular microscopy | |
| 100087-6 | | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100088-4 | | Taenia solium larva Ab bands panel - Serum by Immunoblot | |
| 100089-2 | | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | |
| 10009-9 | | R wave duration in lead V6 | |
| 100090-0 | | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | |
| 100091-8 | | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | |
| 100092-6 | | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | |
| 100093-4 | | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100094-2 | | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100095-9 | | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100096-7 | | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100097-5 | | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100098-3 | | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100099-1 | | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | |
| 1001-7 | | DBG Ab [Presence] in Serum or Plasma from Donor | |
| 10010-7 | | R' wave amplitude in lead AVF | |
| 100100-7 | | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100101-5 | | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100102-3 | | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100103-1 | | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100104-9 | | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100105-6 | | Filaria IgG and IgM panel - Serum | |
| 100106-4 | | Filaria IgG Ab [Presence] in Serum by Immunoassay | |
| 100107-2 | | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100108-0 | | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay | |
| 100109-8 | | Leishmania sp Ab bands panel - Serum by Immunoblot | |
| 10011-5 | | R' wave amplitude in lead AVL | |
| 100110-6 | | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100111-4 | | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100112-2 | | Fasciola sp Ab bands panel - Serum by Immunoblot | |
| 100113-0 | | Helicobacter pylori Ab panel - Serum | |
| 100114-8 | | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | |
| 100115-5 | | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | |
| 100116-3 | | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot | |
| 100117-1 | | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | |
| 100118-9 | | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot | |
| 100119-7 | | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | |
| 10012-3 | | R' wave amplitude in lead AVR | |
| 100120-5 | | Chlamydia trachomatis Ab panel - Serum | |
| 100121-3 | | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay | |
| 100122-1 | | Chlamydophila pneumoniae Ab panel - Serum | |
| 100123-9 | | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | |
| 100124-7 | | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay | |
| 100125-4 | | Chlamydophila psittaci Ab panel - Serum | |
| 100126-2 | | Bordetella pertussis Ab.IgG panel - Serum | |
| 100127-0 | | Campylobacter sp Ab panel - Serum | |
| 100128-8 | | Cryptococcus sp Ag panel - Serum | |
| 100129-6 | | Schistosoma sp Ab [Titer] in Serum by Hemagglutination | |
| 10013-1 | | R' wave amplitude in lead I | |
| 100130-4 | | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | |
| 100131-2 | | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot | |
| 100132-0 | | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot | |
| 100133-8 | | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | |
| 100134-6 | | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot | |
| 100135-3 | | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | |
| 100136-1 | | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot | |
| 100137-9 | | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | |
| 100138-7 | | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot | |
| 100139-5 | | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | |
| 10014-9 | | R' wave amplitude in lead II | |
| 100140-3 | | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot | |
| 100141-1 | | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | |
| 100142-9 | | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot | |
| 100143-7 | | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | |
| 100144-5 | | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot | |
| 100145-2 | | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | |
| 100146-0 | | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot | |
| 100147-8 | | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | |
| 100148-6 | | Schistosoma sp Ab bands panel - Serum by Immunoblot | |
| 100149-4 | | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | |
| 10015-6 | | R' wave amplitude in lead III | |
| 100150-2 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100151-0 | | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100152-8 | | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100153-6 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100154-4 | | Specimen collection supervision level | |
| 100155-1 | | Left cornea Type of Analysis method by Specular microscopy | |
| 100156-9 | | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | |
| 100157-7 | | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | |
| 10016-4 | | R' wave amplitude in lead V1 | |
| 10017-2 | | R' wave amplitude in lead V2 | |
| 10018-0 | | R' wave amplitude in lead V3 | |
| 10019-8 | | R' wave amplitude in lead V4 | |
| 1002-5 | | DBG Ab [Presence] in Serum or Plasma | |
| 10020-6 | | R' wave amplitude in lead V5 | |
| 10021-4 | | R' wave amplitude in lead V6 | |
| 10022-2 | | R' wave duration in lead AVF | |
| 10023-0 | | R' wave duration in lead AVL | |
| 10024-8 | | R' wave duration in lead AVR | |
| 10025-5 | | R' wave duration in lead I | |
| 10026-3 | | R' wave duration in lead II | |
| 10027-1 | | R' wave duration in lead III | |
| 10028-9 | | R' wave duration in lead V1 | |
| 10029-7 | | R' wave duration in lead V2 | |
| 1003-3 | | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | |
| 10030-5 | | R' wave duration in lead V3 | |
| 10031-3 | | R' wave duration in lead V4 | |
| 10032-1 | | R' wave duration in lead V5 | |
| 10033-9 | | R' wave duration in lead V6 | |
| 10034-7 | | S wave amplitude in lead AVF | |
| 10035-4 | | S wave amplitude in lead AVL | |
| 10036-2 | | S wave amplitude in lead AVR | |
| 10037-0 | | S wave amplitude in lead I | |
| 10038-8 | | S wave amplitude in lead II | |
| 10039-6 | | S wave amplitude in lead III | |
| 1004-1 | | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | |
| 10040-4 | | S wave amplitude in lead V1 | |
| 10041-2 | | S wave amplitude in lead V2 | |
| 10042-0 | | S wave amplitude in lead V3 | |
| 10043-8 | | S wave amplitude in lead V4 | |
| 10044-6 | | S wave amplitude in lead V5 | |
| 10045-3 | | S wave amplitude in lead V6 | |
| 10046-1 | | S wave duration in lead AVF | |
| 10047-9 | | S wave duration in lead AVL | |
| 10048-7 | | S wave duration in lead AVR | |
| 10049-5 | | S wave duration in lead I | |
| 1005-8 | | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | |
| 10050-3 | | S wave duration in lead II | |
| 10051-1 | | S wave duration in lead III | |
| 10052-9 | | S wave duration in lead V1 | |
| 10053-7 | | S wave duration in lead V2 | |
| 10054-5 | | S wave duration in lead V3 | |
| 10055-2 | | S wave duration in lead V4 | |
| 10056-0 | | S wave duration in lead V5 | |
| 10057-8 | | S wave duration in lead V6 | |
| 10058-6 | | S' wave amplitude in lead AVF | |
| 10059-4 | | S' wave amplitude in lead AVL | |
| 1006-6 | | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | |
| 10060-2 | | S' wave amplitude in lead AVR | |
| 10061-0 | | S' wave amplitude in lead I | |
| 10062-8 | | S' wave amplitude in lead II | |
| 10063-6 | | S' wave amplitude in lead III | |
| 10064-4 | | S' wave amplitude in lead V1 | |
| 10065-1 | | S' wave amplitude in lead V2 | |
| 10066-9 | | S' wave amplitude in lead V3 | |
| 10067-7 | | S' wave amplitude in lead V4 | |
| 10068-5 | | S' wave amplitude in lead V5 | |
| 10069-3 | | S' wave amplitude in lead V6 | |
| 1007-4 | | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | |
| 10070-1 | | S' wave duration in lead AVF | |
| 10071-9 | | S' wave duration in lead AVL | |
| 10072-7 | | S' wave duration in lead AVR | |
| 10073-5 | | S' wave duration in lead I | |
| 10074-3 | | S' wave duration in lead II | |
| 10075-0 | | S' wave duration in lead III | |
| 10076-8 | | S' wave duration in lead V1 | |
| 10077-6 | | S' wave duration in lead V2 | |
| 10078-4 | | S' wave duration in lead V3 | |
| 10079-2 | | S' wave duration in lead V4 | |
| 1008-2 | | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma | |
| 10080-0 | | S' wave duration in lead V5 | |
| 10081-8 | | S' wave duration in lead V6 | |
| 10082-6 | | ST initial amplitude 6 ms in lead AVF | |
| 10083-4 | | ST initial amplitude 6 ms in lead AVL | |
| 10084-2 | | ST initial amplitude 6 ms in lead AVR | |
| 10085-9 | | ST initial amplitude 6 ms in lead I | |
| 10086-7 | | ST initial amplitude 6 ms in lead II | |
| 10087-5 | | ST initial amplitude 6 ms in lead III | |
| 10088-3 | | ST initial amplitude 6 ms in lead V1 | |
| 10089-1 | | ST initial amplitude 6 ms in lead V2 | |
| 1009-0 | | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | |
| 10090-9 | | ST initial amplitude 6 ms in lead V3 | |
| 10091-7 | | ST initial amplitude 6 ms in lead V4 | |
| 10092-5 | | ST initial amplitude 6 ms in lead V5 | |
| 10093-3 | | ST initial amplitude 6 ms in lead V6 | |
| 10094-1 | | ST slope in lead AVF | |
| 10095-8 | | ST slope in lead AVL | |
| 10096-6 | | ST slope in lead AVR | |
| 10097-4 | | ST slope in lead I | |
| 10098-2 | | ST slope in lead II | |
| 10099-0 | | ST slope in lead III | |
| 101-6 | | Cefoperazone [Susceptibility] by Disk diffusion (KB) | |
| 1010-8 | | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10100-6 | | ST slope in lead V1 | |
| 10101-4 | | ST slope in lead V2 | |
| 10102-2 | | ST slope in lead V3 | |
| 10103-0 | | ST slope in lead V4 | |
| 10104-8 | | ST slope in lead V5 | |
| 10105-5 | | ST slope in lead V6 | |
| 10106-3 | | ST wave end displacement in lead AVF | |
| 10107-1 | | ST wave end displacement in lead AVL | |
| 10108-9 | | ST wave end displacement in lead AVR | |
| 10109-7 | | ST wave end displacement in lead I | |
| 1011-6 | | E sup(w) Ab [Presence] in Serum or Plasma from Donor | |
| 10110-5 | | ST wave end displacement in lead II | |
| 10111-3 | | ST wave end displacement in lead III | |
| 10112-1 | | ST wave end displacement in lead V1 | |
| 10113-9 | | ST wave end displacement in lead V2 | |
| 10114-7 | | ST wave end displacement in lead V3 | |
| 10115-4 | | ST wave end displacement in lead V4 | |
| 10116-2 | | ST wave end displacement in lead V5 | |
| 10117-0 | | ST wave end displacement in lead V6 | |
| 10118-8 | | ST wave mid displacement in lead AVF | |
| 10119-6 | | ST wave mid displacement in lead AVL | |
| 1012-4 | | E sup(w) Ab [Presence] in Serum or Plasma | |
| 10120-4 | | ST wave mid displacement in lead AVR | |
| 10121-2 | | ST wave mid displacement in lead I | |
| 10122-0 | | ST wave mid displacement in lead II | |
| 10123-8 | | ST wave mid displacement in lead III | |
| 10124-6 | | ST wave mid displacement in lead V1 | |
| 10125-3 | | ST wave mid displacement in lead V2 | |
| 10126-1 | | ST wave mid displacement in lead V3 | |
| 10127-9 | | ST wave mid displacement in lead V4 | |
| 10128-7 | | ST wave mid displacement in lead V5 | |
| 10129-5 | | ST wave mid displacement in lead V6 | |
| 1013-2 | | E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10130-3 | | T' wave amplitude in lead AVF | |
| 10131-1 | | T' wave amplitude in lead AVL | |
| 10132-9 | | T' wave amplitude in lead AVR | |
| 10133-7 | | T' wave amplitude in lead I | |
| 10134-5 | | T' wave amplitude in lead II | |
| 10135-2 | | T' wave amplitude in lead III | |
| 10136-0 | | T' wave amplitude in lead V1 | |
| 10137-8 | | T' wave amplitude in lead V2 | |
| 10138-6 | | T' wave amplitude in lead V3 | |
| 10139-4 | | T' wave amplitude in lead V4 | |
| 1014-0 | | E sup(w) Ag [Presence] on Red Blood Cells from Donor | |
| 10140-2 | | T' wave amplitude in lead V5 | |
| 10141-0 | | T' wave amplitude in lead V6 | |
| 10142-8 | | T wave amplitude in lead AVF | |
| 10143-6 | | T wave amplitude in lead AVL | |
| 10144-4 | | T wave amplitude in lead AVR | |
| 10145-1 | | T wave amplitude in lead I | |
| 10146-9 | | T wave amplitude in lead II | |
| 10147-7 | | T wave amplitude in lead III | |
| 10148-5 | | T wave amplitude in lead V1 | |
| 10149-3 | | T wave amplitude in lead V2 | |
| 1015-7 | | E sup(w) Ag [Presence] on Red Blood Cells | |
| 10150-1 | | T wave amplitude in lead V3 | |
| 10151-9 | | T wave amplitude in lead V4 | |
| 10152-7 | | T wave amplitude in lead V5 | |
| 10153-5 | | T wave amplitude in lead V6 | |
| 10154-3 | | Chief complaint Narrative - Reported | |
| 10155-0 | | History of allergies, reported | |
| 10156-8 | | History of Childhood diseases Narrative | |
| 10157-6 | | History of family member diseases Narrative | |
| 10158-4 | | History of Functional status Narrative | |
| 10159-2 | | History of Industrial exposure Narrative | |
| 1016-5 | | E Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10160-0 | | History of Medication use Narrative | |
| 10161-8 | | History of Occupational exposure Narrative | |
| 10162-6 | | History of pregnancies Narrative | |
| 10163-4 | | History of pregnancies | |
| 10164-2 | | History of Present illness Narrative | |
| 10165-9 | | Deprecated History of psychiatric symptoms and diseases Narrative | |
| 10166-7 | | History of Social function Narrative | |
| 10167-5 | | History of Surgical procedures Narrative | |
| 10168-3 | | History of Cardiovascular system disorders Narrative | |
| 10169-1 | | History of Ear disorders Narrative | |
| 1017-3 | | E Ab [Presence] in Serum or Plasma from Donor | |
| 10170-9 | | History of Endocrine system disorders Narrative | |
| 10171-7 | | History of Eyes disorders Narrative | |
| 10172-5 | | History of Hematologic system disorders Narrative | |
| 10173-3 | | History of Musculoskeletal system disorders Narrative | |
| 10174-1 | | History of Nose disorders Narrative | |
| 10175-8 | | History of Oral cavity disorders Narrative | |
| 10176-6 | | History of Reproductive system disorders Narrative | |
| 10177-4 | | History of Respiratory system disorders Narrative | |
| 10178-2 | | History of Skin disorders Narrative | |
| 10179-0 | | History of Throat and Neck disorders Narrative | |
| 1018-1 | | E Ab [Presence] in Serum or Plasma | |
| 10180-8 | | History of Throat and Neck disorders | |
| 10181-6 | | History of Urinary tract disorders Narrative | |
| 10182-4 | | History of Travel Narrative | |
| 10183-2 | | Hospital discharge medications Narrative | |
| 10184-0 | | Hospital discharge physical findings Narrative | |
| 10185-7 | | Hospital discharge procedures Narrative | |
| 10186-5 | | Identifying information Narrative Observed | |
| 10187-3 | | Review of systems Narrative - Reported | |
| 10188-1 | | Review of systems overview Narrative - Reported | |
| 10189-9 | | Review of systems overview - Reported | |
| 1019-9 | | E Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10190-7 | | Mental status Narrative | |
| 10191-5 | | Physical findings of Abdomen Narrative | |
| 10192-3 | | Physical findings of Back Narrative | |
| 10193-1 | | Physical findings of Breasts Narrative | |
| 10194-9 | | Physical findings of Neurologic deep tendon reflexes Narrative | |
| 10195-6 | | Physical findings of Ear Narrative | |
| 10196-4 | | Physical findings of Extremities Narrative | |
| 10197-2 | | Physical findings of Eye Narrative | |
| 10198-0 | | Physical findings of Genitourinary tract Narrative | |
| 10199-8 | | Physical findings of Head Narrative | |
| 102-4 | | Cefoperazone [Susceptibility] by Serum bactericidal titer | |
| 1020-7 | | E Ag [Presence] on Red Blood Cells from Donor | |
| 10200-4 | | Physical findings of Heart Narrative | |
| 10201-2 | | Physical findings of Mouth and Throat and Teeth Narrative | |
| 10202-0 | | Physical findings of Nervous system Narrative | |
| 10203-8 | | Physical findings of Nose Narrative | |
| 10204-6 | | Physical findings of Pelvis Narrative | |
| 10205-3 | | Physical findings of Rectum Narrative | |
| 10206-1 | | Physical findings of Skin Narrative | |
| 10207-9 | | Physical findings of Thorax and Lungs Narrative | |
| 10208-7 | | Physical findings of Vessels Narrative | |
| 10209-5 | | Physical findings of Neurologic balance and Coordination Narrative | |
| 1021-5 | | E Ag [Presence] on Red Blood Cells | |
| 10210-3 | | Physical findings of General status Narrative | |
| 10211-1 | | Physical findings of Sense of touch Narrative | |
| 10212-9 | | Physical findings of Strength Narrative | |
| 10213-7 | | Surgical operation note anesthesia Narrative | |
| 10214-5 | | Surgical operation note anesthesia duration | |
| 10215-2 | | Surgical operation note findings Narrative | |
| 10216-0 | | Surgical operation note fluids Narrative | |
| 10217-8 | | Surgical operation note indications [Interpretation] Narrative | |
| 10218-6 | | Surgical operation note postoperative diagnosis Narrative | |
| 10219-4 | | Surgical operation note preoperative diagnosis Narrative | |
| 1022-3 | | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10220-2 | | Surgical operation note prep time duration | |
| 10221-0 | | Surgical operation note specimens taken Narrative | |
| 10222-8 | | Surgical operation note surgical complications [Interpretation] Narrative | |
| 10223-6 | | Surgical operation note surgical procedure Narrative | |
| 10224-4 | | Hemodynamic method special circumstances | |
| 10225-1 | | Cardiac measurement device Institution inventory number | |
| 10226-9 | | Oxygen content in Intravascular space | |
| 10227-7 | | Cardiac measurement device Vendor model number | |
| 10228-5 | | Cardiac measurement device Vendor serial number | |
| 10229-3 | | Hemodynamic method Type of | |
| 1023-1 | | Fy sup(a) Ab [Presence] in Serum or Plasma from Donor | |
| 10230-1 | | Left ventricular Ejection fraction | |
| 10231-9 | | Right ventricular Ejection fraction | |
| 10232-7 | | Oxygen content in Aorta root | |
| 10233-5 | | Oxygen content in Left atrium | |
| 10234-3 | | Oxygen content in Right atrium | |
| 10235-0 | | Oxygen content in High right atrium | |
| 10236-8 | | Oxygen content in Low right atrium | |
| 10237-6 | | Oxygen content in Mid right atrium | |
| 10238-4 | | Oxygen content in Left ventricle | |
| 10239-2 | | Oxygen content in Right ventricular outflow tract | |
| 1024-9 | | Fy sup(a) Ab [Presence] in Serum or Plasma | |
| 10240-0 | | Oxygen content in Right ventricle | |
| 10241-8 | | Oxygen content in Coronary sinus | |
| 10242-6 | | Oxygen content in Ductus arteriosus | |
| 10243-4 | | Oxygen content in Inferior vena cava | |
| 10244-2 | | Oxygen content in Left pulmonary artery | |
| 10245-9 | | Oxygen content in Main pulmonary artery | |
| 10246-7 | | Oxygen content in Right pulmonary artery | |
| 10247-5 | | Oxygen content in Pulmonary wedge | |
| 10248-3 | | Oxygen content in Superior vena cava | |
| 10249-1 | | Heart rate device Institution inventory number | |
| 1025-6 | | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10250-9 | | Heart rate device Vendor model number | |
| 10251-7 | | Heart rate device Vendor serial number | |
| 10252-5 | | Biliary drain site | |
| 10253-3 | | Type of Biliary drain | |
| 10254-1 | | Type of Peritoneal drain | |
| 10255-8 | | Type of Subarachnoid drain | |
| 10256-6 | | Biliary drain Institution inventory number | |
| 10257-4 | | Chest tube Institution inventory number | |
| 10258-2 | | Enteral tube Institution inventory number | |
| 10259-0 | | Gastrostomy tube Institution inventory number | |
| 1026-4 | | Fy sup(a) Ag [Presence] on Red Blood Cells from Donor | |
| 10260-8 | | GI tube Institution inventory number | |
| 10261-6 | | Intravascular tube Institution inventory number | |
| 10262-4 | | IO tube Institution inventory number | |
| 10263-2 | | Nasogastric tube Institution inventory number | |
| 10264-0 | | Oral tube Institution inventory number | |
| 10265-7 | | Peritoneal drain Institution inventory number | |
| 10266-5 | | Peritoneal tube Institution inventory number | |
| 10267-3 | | Rate control device Institution inventory number | |
| 10268-1 | | Stool collection device Institution inventory number | |
| 10269-9 | | Subarachnoid drain Institution inventory number | |
| 1027-2 | | Fy sup(a) Ag [Presence] on Red Blood Cells | |
| 10270-7 | | Synovial drain Institution inventory number | |
| 10271-5 | | Tube or drain Institution inventory number | |
| 10272-3 | | Upper GI tube Institution inventory number | |
| 10273-1 | | Bladder irrigation tube Institution inventory number | |
| 10274-9 | | Urine tube Institution inventory number | |
| 10275-6 | | Wound drain device Institution inventory number | |
| 10276-4 | | Peritoneal drain site | |
| 10277-2 | | Stool collection site | |
| 10278-0 | | Subarachnoid drain site | |
| 10279-8 | | Biliary drain Vendor model number | |
| 1028-0 | | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10280-6 | | Chest tube Vendor model number | |
| 10281-4 | | Enteral tube Vendor model number | |
| 10282-2 | | Gastrostomy tube Vendor model number | |
| 10283-0 | | GI tube Vendor model number | |
| 10284-8 | | Intravascular tube Vendor model number | |
| 10285-5 | | IO tube Vendor model number | |
| 10286-3 | | Nasogastric tube Vendor model number | |
| 10287-1 | | Oral tube Vendor model number | |
| 10288-9 | | Peritoneal drain Vendor model number | |
| 10289-7 | | Peritoneal tube Vendor model number | |
| 1029-8 | | Fy sup(b) Ab [Presence] in Serum or Plasma from Donor | |
| 10290-5 | | Rate control device Vendor model number | |
| 10291-3 | | Stool collection device Vendor model number | |
| 10292-1 | | Subarachnoid drain Vendor model number | |
| 10293-9 | | Synovial drain Vendor model number | |
| 10294-7 | | Tube or drain Vendor model number | |
| 10295-4 | | Upper GI tube Vendor model number | |
| 10296-2 | | Bladder irrigation tube Vendor model number | |
| 10297-0 | | Urine tube Vendor model number | |
| 10298-8 | | Wound drain device Vendor model number | |
| 10299-6 | | Biliary drain Vendor serial number | |
| 103-2 | | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) | |
| 1030-6 | | Fy sup(b) Ab [Presence] in Serum or Plasma | |
| 10300-2 | | Chest tube Vendor serial number | |
| 10301-0 | | Enteral tube Vendor serial number | |
| 10302-8 | | Gastrostomy tube Vendor serial number | |
| 10303-6 | | GI tube Vendor serial number | |
| 10304-4 | | Intravascular tube Vendor serial number | |
| 10305-1 | | IO tube Vendor serial number | |
| 10306-9 | | Nasogastric tube Vendor serial number | |
| 10307-7 | | Oral tube Vendor serial number | |
| 10308-5 | | Peritoneal drain Vendor serial number | |
| 10309-3 | | Peritoneal tube Vendor serial number | |
| 1031-4 | | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10310-1 | | Rate control device Vendor serial number | |
| 10311-9 | | Stool collection device Vendor serial number | |
| 10312-7 | | Subarachnoid drain Vendor serial number | |
| 10313-5 | | Synovial drain Vendor serial number | |
| 10314-3 | | Tube or drain Vendor serial number | |
| 10315-0 | | Upper GI tube Vendor serial number | |
| 10316-8 | | Bladder irrigation tube Vendor serial number | |
| 10317-6 | | Urine tube Vendor serial number | |
| 10318-4 | | Wound drain device Vendor serial number | |
| 10319-2 | | Enema device Institution inventory number | |
| 1032-2 | | Fy sup(b) Ag [Presence] on Red Blood Cells from Donor | |
| 10320-0 | | Enema device Vendor model number | |
| 10321-8 | | Enema device Vendor serial number | |
| 10322-6 | | Potassium intake 24 hour | |
| 10323-4 | | Wound drain fluid [Appearance] Lower GI tract | |
| 10324-2 | | Breath rate device Institution inventory number | |
| 10325-9 | | Breath rate device Vendor model number | |
| 10326-7 | | Breath rate device Vendor serial number | |
| 10327-5 | | Eosinophils/100 leukocytes in Sputum by Manual count | |
| 10328-3 | | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count | |
| 10329-1 | | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count | |
| 1033-0 | | Fy sup(b) Ag [Presence] on Red Blood Cells | |
| 10330-9 | | Monocytes/100 leukocytes in Body fluid by Manual count | |
| 10331-7 | | Rh [Type] in Blood | |
| 10332-5 | | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM | |
| 10333-3 | | Appearance of Cerebral spinal fluid | |
| 10334-1 | | Cancer Ag 125 [Units/volume] in Serum or Plasma | |
| 10335-8 | | Color of Cerebral spinal fluid | |
| 10336-6 | | Gonadotropin peptide [Mass/volume] in Urine | |
| 10337-4 | | Procollagen type I [Mass/volume] in Serum | |
| 10338-2 | | Barbiturates [Mass/volume] in Serum or Plasma | |
| 10339-0 | | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | |
| 1034-8 | | Fetal cell screen [Interpretation] in Blood | |
| 10340-8 | | Molindone [Mass/volume] in Serum or Plasma | |
| 10341-6 | | Norpropoxyphene [Mass/volume] in Serum or Plasma | |
| 10342-4 | | Sulfamethoxazole [Mass/volume] in Serum or Plasma | |
| 10343-2 | | Temazepam [Mass/volume] in Serum or Plasma | |
| 10344-0 | | Tranylcypromine [Mass/volume] in Serum or Plasma | |
| 10345-7 | | Trihexyphenidyl [Mass/volume] in Urine | |
| 10346-5 | | Hemoglobin A [Units/volume] in Blood by Electrophoresis | |
| 10347-3 | | Babesia microti identified in Blood by Light microscopy | |
| 10348-1 | | Bordetella parapertussis Ab [Presence] in Serum | |
| 10349-9 | | Brucella sp Ab [Units/volume] in Serum | |
| 1035-5 | | Fresh frozen plasma given [Volume] | |
| 10350-7 | | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay | |
| 10351-5 | | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | |
| 10352-3 | | Bacteria identified in Genital specimen by Aerobe culture | |
| 10353-1 | | Bacteria identified in Nose by Aerobe culture | |
| 10354-9 | | Bacteria identified in Urethra by Culture | |
| 10355-6 | | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain | |
| 10356-4 | | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain | |
| 10357-2 | | Microscopic observation [Identifier] in Wound by Gram stain | |
| 10358-0 | | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) | |
| 10359-8 | | Asialoganglioside GM1 IgM Ab [Titer] in Serum | |
| 1036-3 | | G Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10360-6 | | DNA single strand IgG Ab [Units/volume] in Serum | |
| 10361-4 | | DNA single strand IgM Ab [Units/volume] in Serum | |
| 10362-2 | | Endomysium IgA Ab [Presence] in Serum | |
| 10363-0 | | Barbiturates [Presence] in Specimen | |
| 10364-8 | | Cotinine [Mass/mass] in Hair | |
| 10365-5 | | Cotinine [Mass/volume] in Serum or Plasma | |
| 10366-3 | | Cotinine [Mass/volume] in Urine | |
| 10367-1 | | Ethanol [Mass/volume] in Gastric fluid | |
| 10368-9 | | Lead [Mass/volume] in Capillary blood | |
| 10369-7 | | Opiates [Mass/mass] in Hair | |
| 1037-1 | | G Ab [Presence] in Serum or Plasma from Donor | |
| 10370-5 | | Phencyclidine [Mass/mass] in Hair | |
| 10371-3 | | Bite cells [Presence] in Blood by Light microscopy | |
| 10372-1 | | Blister cells [Presence] in Blood by Light microscopy | |
| 10373-9 | | Fragments [Presence] in Blood by Light microscopy | |
| 10374-7 | | Helmet cells [Presence] in Blood by Light microscopy | |
| 10375-4 | | Irregularly contracted cells [Presence] in Blood by Light microscopy | |
| 10376-2 | | Oval macrocytes [Presence] in Blood by Light microscopy | |
| 10377-0 | | Pencil cells [Presence] in Blood by Light microscopy | |
| 10378-8 | | Polychromasia [Presence] in Blood by Light microscopy | |
| 10379-6 | | Erythrocytes.dual population [Presence] in Blood by Light microscopy | |
| 1038-9 | | G Ab [Presence] in Serum or Plasma | |
| 10380-4 | | Stomatocytes [Presence] in Blood by Light microscopy | |
| 10381-2 | | Target cells [Presence] in Blood by Light microscopy | |
| 10382-0 | | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10383-8 | | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Donor | |
| 10384-6 | | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells | |
| 10385-3 | | Albumin concentration given | |
| 10386-1 | | Albumin given [Volume] | |
| 10387-9 | | Autologous erythrocytes given [Volume] | |
| 10388-7 | | Autologous whole blood given [Volume] | |
| 10389-5 | | Blood product.other [Type] | |
| 1039-7 | | G Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10390-3 | | Blood product special preparation [Type] | |
| 10391-1 | | Cytomegalovirus immune globulin given [Volume] | |
| 10392-9 | | Cryoprecipitate given [Volume] | |
| 10393-7 | | Factor IX given [Type] | |
| 10394-5 | | Factor IX given [Volume] | |
| 10395-2 | | Factor VIII given [Type] | |
| 10396-0 | | Factor VIII given [Volume] | |
| 10397-8 | | Hepatitis B immune globulin given [Volume] | |
| 10398-6 | | I Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10399-4 | | I Ag [Presence] on Red Blood Cells from Donor | |
| 104-0 | | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 1040-5 | | G Ag [Presence] on Red Blood Cells from Donor | |
| 10400-0 | | I Ag [Presence] on Red Blood Cells | |
| 10401-8 | | Immune serum globulin given [Type] | |
| 10402-6 | | Immune serum globulin given [Volume] | |
| 10403-4 | | Inject immune serum globulin [Volume] | |
| 10404-2 | | Inject Rh immune globulin [Volume] | |
| 10405-9 | | Inject varicella zoster virus immune globulin [Volume] | |
| 10406-7 | | little i Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10407-5 | | little i Ag [Presence] on Red Blood Cells from Donor | |
| 10408-3 | | little i Ag [Presence] on Red Blood Cells | |
| 10409-1 | | Pentaspan given [Volume] | |
| 1041-3 | | G Ag [Presence] on Red Blood Cells | |
| 10410-9 | | Plasma given [Type] | |
| 10411-7 | | Plasma given [Volume] | |
| 10412-5 | | Platelets given [Type] | |
| 10413-3 | | Rh immune globulin given [Volume] | |
| 10414-1 | | Transfuse albumin [Volume] | |
| 10415-8 | | Transfuse blood exchange transfusion [Volume] | |
| 10416-6 | | Transfuse blood product other [Volume] | |
| 10417-4 | | Transfuse cryoprecipitate [Volume] | |
| 10418-2 | | Transfuse factor IX [Volume] | |
| 10419-0 | | Transfuse factor VIII [Volume] | |
| 1042-1 | | H Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10420-8 | | Transfuse immune serum globulin [Volume] | |
| 10421-6 | | Transfuse Pentaspan [Volume] | |
| 10422-4 | | Transfuse plasma [Volume] | |
| 10423-2 | | Transfuse platelets [Volume] | |
| 10424-0 | | Transfuse erythrocytes [Volume] | |
| 10425-7 | | Transfuse Rh immune globulin [Volume] | |
| 10426-5 | | Transfuse whole blood [Volume] | |
| 10427-3 | | Transfuse whole blood autologous [Volume] | |
| 10428-1 | | Varicella zoster virus immune globulin given [Volume] | |
| 10429-9 | | AE 1 Ag [Presence] in Tissue by Immune stain | |
| 1043-9 | | H Ab [Presence] in Serum or Plasma from Donor | |
| 10430-7 | | AE 3 Ag [Presence] in Tissue by Immune stain | |
| 10431-5 | | B-cell Ag [Presence] in Tissue by Immune stain | |
| 10432-3 | | CD30 Ag [Presence] in Tissue by Immune stain | |
| 10433-1 | | BR-2 Ag [Presence] in Tissue by Immune stain | |
| 10434-9 | | Complement C3 Ag [Presence] in Tissue by Immune stain | |
| 10435-6 | | C5B-9 Ag [Presence] in Tissue by Immune stain | |
| 10436-4 | | CD15 Ag [Presence] in Tissue by Immune stain | |
| 10437-2 | | CD16 Ag [Presence] in Tissue by Immune stain | |
| 10438-0 | | CD20 Ag [Presence] in Tissue by Immune stain | |
| 10439-8 | | CD3 Ag [Presence] in Tissue by Immune stain | |
| 1044-7 | | H Ab [Presence] in Serum | |
| 10440-6 | | Deprecated CD30 Ag [Presence] in Tissue by Immune stain | |
| 10441-4 | | CD34 Ag [Presence] in Tissue by Immune stain | |
| 10442-2 | | CD56 Ag [Presence] in Tissue by Immune stain | |
| 10443-0 | | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain | |
| 10444-8 | | CD57 Ag [Presence] in Tissue by Immune stain | |
| 10445-5 | | CD11c Ag [Presence] in Tissue by Immune stain | |
| 10446-3 | | Leukocyte common Ag [Presence] in Tissue by Immune stain | |
| 10447-1 | | M-5 Ag [Presence] in Tissue by Immune stain | |
| 10448-9 | | T-cell Ag [Presence] in Tissue by Immune stain | |
| 10449-7 | | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal | |
| 1045-4 | | Deprecated H NOS Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10450-5 | | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting | |
| 10451-3 | | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting | |
| 10452-1 | | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO | |
| 10453-9 | | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO | |
| 10454-7 | | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO | |
| 10455-4 | | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO | |
| 10456-2 | | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting | |
| 10457-0 | | Actin Ag [Presence] in Tissue by Immune stain | |
| 10458-8 | | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain | |
| 10459-6 | | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain | |
| 1046-2 | | Deprecated H NOS Ab [Presence] in Serum or Plasma from Donor | |
| 10460-4 | | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain | |
| 10461-2 | | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain | |
| 10462-0 | | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain | |
| 10463-8 | | Amyloid A component Ag [Presence] in Tissue by Immune stain | |
| 10464-6 | | Amyloid P component Ag [Presence] in Tissue by Immune stain | |
| 10465-3 | | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain | |
| 10466-1 | | Anion gap 3 in Serum or Plasma | |
| 10467-9 | | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain | |
| 10468-7 | | Calcitonin Ag [Presence] in Tissue by Immune stain | |
| 10469-5 | | Carcinoembryonic Ag [Presence] in Tissue by Immune stain | |
| 1047-0 | | Deprecated H NOS Ab [Presence] in Serum or Plasma | |
| 10470-3 | | Choriogonadotropin Ag [Presence] in Tissue by Immune stain | |
| 10471-1 | | Chromogranin A Ag [Presence] in Tissue by Immune stain | |
| 10472-9 | | Chromogranin Ag [Presence] in Tissue by Immune stain | |
| 10473-7 | | Chymotrypsin Ag [Presence] in Tissue by Immune stain | |
| 10474-5 | | Collagen type 4 Ag [Presence] in Tissue by Immune stain | |
| 10475-2 | | Corticotropin Ag [Presence] in Tissue by Immune stain | |
| 10476-0 | | Desmin Ag [Presence] in Tissue by Immune stain | |
| 10477-8 | | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain | |
| 10478-6 | | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain | |
| 10479-4 | | CD227 Ag [Presence] in Tissue by Immune stain | |
| 1048-8 | | Deprecated H NOS Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10480-2 | | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain | |
| 10481-0 | | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain | |
| 10482-8 | | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain | |
| 10483-6 | | Gastrin Ag [Presence] in Tissue by Immune stain | |
| 10484-4 | | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain | |
| 10485-1 | | Glucagon Ag [Presence] in Tissue by Immune stain | |
| 10486-9 | | Hemoglobin Ag [Presence] in Tissue by Immune stain | |
| 10487-7 | | HMB-45 Ag [Presence] in Tissue by Immune stain | |
| 10488-5 | | IgA Ag [Presence] in Tissue by Immune stain | |
| 10489-3 | | IgA.heavy chain Ag [Presence] in Tissue by Immune stain | |
| 1049-6 | | Deprecated H NOS Ag [Presence] on Red Blood Cells from Donor | |
| 10490-1 | | IgE Ag [Presence] in Tissue by Immune stain | |
| 10491-9 | | IgG Ag [Presence] in Tissue by Immune stain | |
| 10492-7 | | IgG.heavy chain Ag [Presence] in Tissue by Immune stain | |
| 10493-5 | | IgM Ag [Presence] in Tissue by Immune stain | |
| 10494-3 | | IgM.heavy chain Ag [Presence] in Tissue by Immune stain | |
| 10495-0 | | Insulin Ag [Presence] in Tissue by Immune stain | |
| 10496-8 | | Kappa light chains Ag [Presence] in Tissue by Immune stain | |
| 10497-6 | | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain | |
| 10498-4 | | Keratin Ag [Presence] in Tissue by Immune stain | |
| 10499-2 | | Lambda light chains Ag [Presence] in Tissue by Immune stain | |
| 105-7 | | Ceforanide [Susceptibility] by Disk diffusion (KB) | |
| 1050-4 | | Deprecated H NOS Ag [Presence] on Red Blood Cells | |
| 10500-7 | | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain | |
| 10501-5 | | Lutropin [Units/volume] in Serum or Plasma | |
| 10502-3 | | Lutropin Ag [Presence] in Tissue by Immune stain | |
| 10503-1 | | Lysozyme Ag [Presence] in Tissue by Immune stain | |
| 10504-9 | | Myelin basic protein Ag [Presence] in Tissue by Immune stain | |
| 10505-6 | | Myoglobin Ag [Presence] in Tissue by Immune stain | |
| 10506-4 | | Peanut agglutinin Ag [Presence] in Tissue by Immune stain | |
| 10507-2 | | Prolactin Ag [Presence] in Tissue by Immune stain | |
| 10508-0 | | Prostate specific Ag [Presence] in Tissue by Immune stain | |
| 10509-8 | | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain | |
| 1051-2 | | Hemolytic disease of newborn screen [Interpretation] in Blood | |
| 10510-6 | | S-100 Ag [Presence] in Tissue by Immune stain | |
| 10511-4 | | Serotonin Ag [Presence] in Tissue by Immune stain | |
| 10512-2 | | Somatostatin Ag [Presence] in Tissue by Immune stain | |
| 10513-0 | | Somatotropin Ag [Presence] in Tissue by Immune stain | |
| 10514-8 | | Synaptophysin Ag [Presence] in Tissue by Immune stain | |
| 10515-5 | | Thyroglobulin Ag [Presence] in Tissue by Immune stain | |
| 10516-3 | | Thyrotropin Ag [Presence] in Tissue by Immune stain | |
| 10517-1 | | Trypsin Ag [Presence] in Tissue by Immune stain | |
| 10518-9 | | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain | |
| 10519-7 | | Vimentin Ag [Presence] in Tissue by Immune stain | |
| 1052-0 | | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit | |
| 10520-5 | | Coagulation factor VI Ag [Presence] in Tissue by Immune stain | |
| 10521-3 | | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain | |
| 10522-1 | | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain | |
| 10523-9 | | Fibrinogen Ag [Presence] in Tissue by Immune stain | |
| 10524-7 | | Microscopic observation [Identifier] in Cervix by Cyto stain | |
| 10525-4 | | Microscopic observation [Identifier] in Specimen by Cyto stain | |
| 10526-2 | | Microscopic observation [Identifier] in Sputum by Cyto stain | |
| 10527-0 | | Microscopic observation [Identifier] in Tissue by Cyto stain | |
| 10528-8 | | Acetophenazine [Mass/volume] in Serum or Plasma | |
| 10529-6 | | Amoxapine metabolite [Mass/volume] in Serum or Plasma | |
| 1053-8 | | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor | |
| 10530-4 | | Aprobarbital [Mass/volume] in Serum or Plasma | |
| 10531-2 | | Bretylium [Mass/volume] in Serum or Plasma | |
| 10532-0 | | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma | |
| 10533-8 | | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma | |
| 10534-6 | | Diazoxide [Mass/volume] in Serum or Plasma | |
| 10535-3 | | Digoxin [Mass/volume] in Serum or Plasma | |
| 10536-1 | | Dipyridamole [Mass/volume] in Serum or Plasma | |
| 10537-9 | | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma | |
| 10538-7 | | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | |
| 10539-5 | | glipiZIDE [Mass/volume] in Serum or Plasma | |
| 1054-6 | | Deprecated I (intermediate) subtype [Presence] in srum | |
| 10540-3 | | glyBURIDE [Mass/volume] in Serum or Plasma | |
| 10541-1 | | Mepivacaine [Mass/volume] in Serum or Plasma | |
| 10542-9 | | Metharbital [Mass/volume] in Serum or Plasma | |
| 10543-7 | | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma | |
| 10544-5 | | Normeperidine [Presence] in Serum or Plasma | |
| 10545-2 | | Normephenytoin [Mass/volume] in Serum or Plasma | |
| 10546-0 | | Normethsuximide [Mass/volume] in Serum or Plasma | |
| 10547-8 | | Primidone+PHENobarbital [Mass/volume] in Serum or Plasma | |
| 10548-6 | | Phenytoin Free/Phenytoin.total in Serum or Plasma | |
| 10549-4 | | Pirmenol [Mass/volume] in Serum or Plasma | |
| 1055-3 | | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit | |
| 10550-2 | | Deprecated Temazepam [Mass/volume] in Serum or Plasma | |
| 10551-0 | | Triamterene [Mass/volume] in Serum or Plasma | |
| 10552-8 | | Tricyclic antidepressants [Mass/volume] in Serum or Plasma | |
| 10553-6 | | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid | |
| 10554-4 | | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma | |
| 10555-1 | | Acrosin [Entitic Catalytic Activity] in Spermatozoa | |
| 10556-9 | | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma | |
| 10557-7 | | Adenosine triphosphate [Moles/volume] in Semen | |
| 10558-5 | | Albumin [Moles/volume] in Semen | |
| 10559-3 | | Deprecated Calcium [Molecules/volume] in Semen | |
| 1056-1 | | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor | |
| 10560-1 | | Carcinoembryonic Ag [Units/volume] in Semen | |
| 10561-9 | | Carnitine [Moles/volume] in Semen | |
| 10562-7 | | Cells [#/volume] in Cervical mucus | |
| 10563-5 | | Cells other than spermatozoa [#/volume] in Semen | |
| 10564-3 | | Cervical mucus [Volume] | |
| 10565-0 | | Choriogonadotropin [Units/volume] in Semen | |
| 10566-8 | | Deprecated Choriogonadotropin [Molecules/volume] in Semen | |
| 10567-6 | | Citrate [Moles/volume] in Semen | |
| 10568-4 | | Clarity of Semen | |
| 10569-2 | | Color of Semen | |
| 1057-9 | | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells | |
| 10570-0 | | Consistency of Cervical mucus | |
| 10571-8 | | Deprecated Consistency of Semen | |
| 10572-6 | | Deprecated Duration^post ejaculation | |
| 10573-4 | | Ferning [Type] in Cervical mucus | |
| 10574-2 | | Fructose [Moles/volume] in Semen | |
| 10575-9 | | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen | |
| 10576-7 | | Germ cells.immature [#/volume] in Semen | |
| 10577-5 | | Glucosidase [Enzymatic activity/volume] in Seminal plasma | |
| 10578-3 | | Glycerophosphocholine [Moles/volume] in Seminal plasma | |
| 10579-1 | | Leukocytes [#/volume] in Semen | |
| 1058-7 | | I Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10580-9 | | Liquefaction [Time] in Semen | |
| 10581-7 | | Deprecated Number of entities [#] in Spermatozoa | |
| 10582-5 | | pH of Cervical mucus | |
| 10583-3 | | Prostaglandin F1 alpha [Moles/volume] in Semen | |
| 10584-1 | | Deprecated Protein [Mass/volume] in Semen | |
| 10585-8 | | Round cells [#/volume] in Semen | |
| 10586-6 | | Deprecated Volume of Semen | |
| 10587-4 | | Sexual abstinence duration | |
| 10588-2 | | Spermatogonia [#/volume] in Semen | |
| 10589-0 | | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) | |
| 1059-5 | | I Ab [Presence] in Serum or Plasma from Donor | |
| 10590-8 | | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) | |
| 10591-6 | | Primary Spermatocytes [#/volume] in Semen | |
| 10592-4 | | Secondary Spermatocytes [#/volume] in Semen | |
| 10593-2 | | Spermatozoa Pyriform Head/100 spermatozoa in Semen | |
| 10594-0 | | Spermatozoa Tapering Head/100 spermatozoa in Semen | |
| 10595-7 | | Deprecated Spermatozoa [#/volume] in Semen | |
| 10596-5 | | Deprecated Spermatozoa Ab in cervical mucosa | |
| 10597-3 | | Deprecated Spermatozoa Ab in semen | |
| 10598-1 | | Deprecated Spermatozoa Ab in serum | |
| 10599-9 | | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test | |
| 106-5 | | Ceforanide [Susceptibility] by Serum bactericidal titer | |
| 1060-3 | | I Ab [Presence] in Serum or Plasma | |
| 10600-5 | | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa | |
| 10601-3 | | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus | |
| 10602-1 | | Spermatozoa Abnormal Head/100 spermatozoa in Semen | |
| 10603-9 | | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen | |
| 10604-7 | | Spermatozoa Abnormal Tail/100 spermatozoa in Semen | |
| 10605-4 | | Spermatozoa Agglutinated/100 spermatozoa in Semen | |
| 10606-2 | | Spermatozoa Amorphous Head/100 spermatozoa in Semen | |
| 10607-0 | | Spermatozoa Coiled Tail/100 spermatozoa in Semen | |
| 10608-8 | | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen | |
| 10609-6 | | Spermatozoa Duplicate Head/100 spermatozoa in Semen | |
| 1061-1 | | Deprecated I NOS Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10610-4 | | Spermatozoa Duplicate Tail/100 spermatozoa in Semen | |
| 10611-2 | | Spermatozoa Immotile/100 spermatozoa in Semen | |
| 10612-0 | | Spermatozoa Large Oval Head/100 spermatozoa in Semen | |
| 10613-8 | | Spermatozoa Viable/100 spermatozoa in Semen | |
| 10614-6 | | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead | |
| 10615-3 | | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction | |
| 10616-1 | | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead | |
| 10617-9 | | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction | |
| 10618-7 | | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead | |
| 10619-5 | | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction | |
| 1062-9 | | Deprecated I NOS Ab [Presence] in Serum or Plasma from Donor | |
| 10620-3 | | Spermatozoa Nonprogressive/100 spermatozoa in Semen | |
| 10621-1 | | Spermatozoa Normal Head/100 spermatozoa in Semen | |
| 10622-9 | | Spermatozoa Normal/100 spermatozoa in Semen | |
| 10623-7 | | Spermatozoa Pin Head/100 spermatozoa in Semen | |
| 10624-5 | | Spermatozoa Rapid/100 spermatozoa in Semen | |
| 10625-2 | | Spermatozoa Round Head/100 spermatozoa in Semen | |
| 10626-0 | | Spermatozoa Slow/100 spermatozoa in Semen | |
| 10627-8 | | Spermatozoa Small Oval Head/100 spermatozoa in Semen | |
| 10628-6 | | Spermatozoa Tail Swelling/100 spermatozoa in Semen | |
| 10629-4 | | Spermatozoa Vacuolated Head/100 spermatozoa in Semen | |
| 1063-7 | | Deprecated I NOS Ab [Presence] in Serum or Plasma | |
| 10630-2 | | Spinnbarkeit [Length] in Cervical mucus | |
| 10631-0 | | Testosterone [Moles/volume] in Semen | |
| 10632-8 | | Time until next menstrual period | |
| 10633-6 | | Zinc [Moles/volume] in Semen | |
| 10634-4 | | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma | |
| 10635-1 | | Acanthamoeba sp identified in Eye by Organism specific culture | |
| 10636-9 | | Acanthamoeba sp identified in Eye by Wet preparation | |
| 10637-7 | | Microscopic observation [Identifier] in Tissue by Night blue stain | |
| 10638-5 | | Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture | |
| 10639-3 | | Thermophilic Actinomycetes identified in Specimen by Organism specific culture | |
| 1064-5 | | Deprecated I NOS Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10640-1 | | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy | |
| 10641-9 | | Amoeba identified in Aspirate by Immune stain | |
| 10642-7 | | Amoeba identified in Aspirate by Wet preparation | |
| 10643-5 | | Amoeba identified in Stool by Organism specific culture | |
| 10644-3 | | Arthropod identified in Specimen | |
| 10645-0 | | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence | |
| 10646-8 | | Astrovirus [Identifier] in Stool by Electron microscopy | |
| 10647-6 | | Babesia sp identified in Blood by Thick film | |
| 10648-4 | | Babesia sp identified in Blood by Thin film | |
| 10649-2 | | Calicivirus [Identifier] in Stool by Electron microscopy | |
| 1065-2 | | Deprecated I NOS Ag [Presence] on Red Blood Cells from Donor | |
| 10650-0 | | Candida sp DNA [Presence] in Blood by Probe with amplification | |
| 10651-8 | | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial | |
| 10652-6 | | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification | |
| 10653-4 | | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 10654-2 | | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) | |
| 10655-9 | | Coccidia identified in Duodenal fluid by Acid fast stain | |
| 10656-7 | | Coccidia identified in Stool by Acid fast stain | |
| 10657-5 | | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence | |
| 10658-3 | | Cyanobacterium identified in Water by Light microscopy | |
| 10659-1 | | Cyclospora sp identified in Stool by Acid fast stain | |
| 1066-0 | | Deprecated I NOS Ag [Presence] on Red Blood Cells | |
| 10660-9 | | Cytomegalovirus Ag [Presence] in Tissue by Immune stain | |
| 10661-7 | | Dinoflagellate identified in Water by Light microscopy | |
| 10662-5 | | Filaria identified in Blood by Concentration | |
| 10663-3 | | Filaria identified in Blood by Thick film | |
| 10664-1 | | Filaria identified in Blood by Thin film | |
| 10665-8 | | Fungus colony count [#/volume] in Specimen by Environmental culture | |
| 10666-6 | | Fungus identified in Tissue by Fontana-Masson stain | |
| 10667-4 | | Fungus identified in Specimen by Animal inoculation | |
| 10668-2 | | Fungus identified in Specimen by Environmental culture | |
| 10669-0 | | Fungus identified in Specimen by Sticky tape for environmental fungus | |
| 1067-8 | | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10670-8 | | Giardia lamblia [Presence] in Stool by Organism specific culture | |
| 10671-6 | | Helminth identified in Specimen | |
| 10672-4 | | Helminth+Arthropod identified in Specimen | |
| 10673-2 | | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain | |
| 10674-0 | | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain | |
| 10675-7 | | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain | |
| 10676-5 | | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | |
| 10677-3 | | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain | |
| 10678-1 | | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain | |
| 10679-9 | | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain | |
| 1068-6 | | Jk sup(a) Ab [Presence] in Serum or Plasma from Donor | |
| 10680-7 | | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy | |
| 10681-5 | | Herpes simplex virus identified in Tissue by Electron microscopy | |
| 10682-3 | | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification | |
| 10683-1 | | Hydatid cyst identified in Aspirate by Immune stain | |
| 10684-9 | | Hydatid cyst identified in Liver by Wet preparation | |
| 10685-6 | | Hydatid cyst identified in Lung tissue by Wet preparation | |
| 10686-4 | | Leishmania sp identified in Tissue by Giemsa stain | |
| 10687-2 | | Leishmania sp identified in Tissue by Organism specific culture | |
| 10688-0 | | Microscopic observation [Identifier] in Hair by KOH preparation | |
| 10689-8 | | Microscopic observation [Identifier] in Nail by KOH preparation | |
| 1069-4 | | Jk sup(a) Ab [Presence] in Serum or Plasma | |
| 10690-6 | | Microsporidia identified in Duodenal fluid by Trichrome stain modified | |
| 10691-4 | | Mushroom.toxic identified by Inspection | |
| 10692-2 | | Mushroom.toxic identified in Food by Light microscopy | |
| 10693-0 | | Mushroom.toxic identified in Vomitus by Light microscopy | |
| 10694-8 | | Naegleria sp identified in Tissue by Organism specific culture | |
| 10695-5 | | Naegleria sp identified in Tissue by Wet preparation | |
| 10696-3 | | Norovirus [Identifier] in Stool by Electron microscopy | |
| 10697-1 | | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 10698-9 | | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) | |
| 10699-7 | | Onchocerca sp identified in Tissue by Wet preparation | |
| 107-3 | | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) | |
| 1070-2 | | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10700-3 | | Orthopoxvirus [Identifier] in Skin by Electron microscopy | |
| 10701-1 | | Ova and parasites identified in Stool by Concentration | |
| 10702-9 | | Ova and parasites identified in Stool by Immune stain | |
| 10703-7 | | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain | |
| 10704-5 | | Ova and parasites identified in Stool by Light microscopy | |
| 10705-2 | | Human papilloma virus Ag [Presence] in Tissue by Immune stain | |
| 10706-0 | | Picornavirus [Identifier] in Stool by Electron microscopy | |
| 10707-8 | | Toxic Plant identified in Plant specimen by Inspection | |
| 10708-6 | | Toxic Plant identified in Vomitus by Light microscopy | |
| 10709-4 | | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence | |
| 1071-0 | | Jk sup(a) Ag [Presence] on Red Blood Cells from Donor | |
| 10710-2 | | Plasmodium sp identified in Blood by Thin film | |
| 10711-0 | | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence | |
| 10712-8 | | Pneumocystis sp identified in Lung tissue | |
| 10713-6 | | Prototheca identified in Specimen by Culture | |
| 10714-4 | | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy | |
| 10715-1 | | Schistosoma sp identified in Urine sediment by Light microscopy | |
| 10716-9 | | Schistosoma sp identified in Specimen by Organism specific culture | |
| 10717-7 | | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination | |
| 10718-5 | | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay | |
| 10719-3 | | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot | |
| 1072-8 | | Jk sup(a) Ag [Presence] on Red Blood Cells | |
| 10720-1 | | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 10721-9 | | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) | |
| 10722-7 | | Torovirus [Identifier] in Stool by Electron microscopy | |
| 10723-5 | | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay | |
| 10724-3 | | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay | |
| 10725-0 | | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification | |
| 10726-8 | | Toxoplasma gondii [Presence] in Tissue by Giemsa stain | |
| 10727-6 | | Toxoplasma gondii identified in Tissue | |
| 10728-4 | | Trichomonas sp identified in Genital specimen by Organism specific culture | |
| 10729-2 | | Trypanosoma sp identified in Blood by Light microscopy | |
| 1073-6 | | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10730-0 | | Trypanosoma sp identified in Blood by Organism specific culture | |
| 10731-8 | | Trypanosoma sp identified in Blood by Thick film | |
| 10732-6 | | Trypanosoma sp identified in Blood by Thin film | |
| 10733-4 | | Trypanosoma sp identified in Blood by Wet preparation | |
| 10734-2 | | Varicella zoster virus identified in Skin by Electron microscopy | |
| 10735-9 | | Viral sequencing [Identifier] in Serum by Sequencing | |
| 10736-7 | | Virus identified in Cerebral spinal fluid by Electron microscopy | |
| 10737-5 | | Virus identified in Stool by Electron microscopy | |
| 10738-3 | | Virus identified in Tissue by Electron microscopy | |
| 10739-1 | | Virus identified in Specimen by Electron microscopy | |
| 1074-4 | | Jk sup(b) Ab [Presence] in Serum or Plasma from Donor | |
| 10740-9 | | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain | |
| 10741-7 | | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain | |
| 10742-5 | | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified | |
| 10743-3 | | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain | |
| 10744-1 | | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain | |
| 10745-8 | | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain | |
| 10746-6 | | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain | |
| 10747-4 | | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain | |
| 10748-2 | | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain | |
| 10749-0 | | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain | |
| 1075-1 | | Jk sup(b) Ab [Presence] in Serum or Plasma | |
| 10750-8 | | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson | |
| 10751-6 | | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain | |
| 10752-4 | | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain | |
| 10753-2 | | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain | |
| 10754-0 | | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain | |
| 10755-7 | | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott | |
| 10756-5 | | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain | |
| 10757-3 | | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald | |
jurisdiction[0]
Concept